Navigation Links
New tool to assess excessive daytime sleepiness in adolescents published in JCSM

WESTCHESTER, Ill. A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) features the Cleveland Adolescent Sleepiness Questionnaire (CASQ), a new self-completed instrument to measure excessive daytime sleepiness in adolescents.

The study, led by James C. Spilsbury, PhD, of the Division of Clinical Epidemiology and Biostatistics in Cleveland, Ohio, focused on a subsample of 411 adolescents between 11-17 years of age, who were recruited from area schools and churches, as well as a second subsample of 62 adolescents with a diagnosed sleep related breathing disorder, all of whom completed the CASQ along with two other surveys measuring daytime sleepiness and other sleep parameters (sleep duration on school nights, sleep duration on non-school nights, and sleep debt). The third source of adolescents for the sample consisted of participants in a community-based cohort study (Cleveland Sleep and Health Study) who did not have evidence of a sleep related breathing disorder by objective overnight polysomnographic monitoring or reported snoring.

According to the study, the CASQs internal consistency was good. Correlations between the CASQ and the two other surveys measuring daytime sleepiness and sleep parameters gave preliminary evidence of the CASQs construct validity based on the following findings:

  • Greater CASQ scores, reflecting increased daytime sleepiness, were significantly associated with decreased sleep duration in both normative and sleep disorder samples, as well as with increased sleep debt in the normative sample.

  • CASQ scores were positively correlated with age.

  • The CASQ displayed convergent validity by its strong positive correlations with the two other surveys measuring daytime sleepiness and other sleep parameters.

  • Adolescents with a sleep related breathing disorder had higher CASQ scores than adolescents without a sleep related breathing disorder.

  • The CASQ detected differences in daytime sleepiness between both normal controls and primary snorers, and between normal controls and adolescents with OSA.

  • In contrast to the CASQ, one of the two other surveys did not detect significant differences in sleepiness between adolescent controls and those with OSA, while the second survey did not detect differences between primary snorers and controls.

  • The CASQ was associated with objective measures derived from the polysomnograms, or a sleep test.

The CASQ shows promise as a valid measure of daytime sleepiness in adolescents, said Dr. Spilsbury, who added that future research should examine the association between the CASQ and additional objective measures of sleepiness and sleep duration, as well as the inclusion of participants with greater social and ethnic diversity and those with other sleep disorders or problems.

Administering the CASQ to groups of adolescents with other known sleep disorders would provide additional information about clinically significant score cut-off points. Having a brief, valid and inexpensive measure of daytime sleepiness at their disposal would enable clinicians to avoid the more costly and burdensome multiple sleep latency test. Such an instrument could also be used as a simple, inexpensive way to monitor patient responses to treatment for sleep problems or disorders, added Dr. Spilsbury.


Contact: Jim Arcuri
American Academy of Sleep Medicine

Related medicine news :

1. Researchers Scale to assess the Severity of Epilepsy in Kids
2. Assessment for hearing aid implants in the process
3. Time to re-assess lung donation concept
4. Nurses competing with junior doctors in some assessments
5. Assessing Prostate Cancer Risk
6. Scientists Developed Cheap Way To Assess Sleep
7. Risk of colon cancer to be assessed by simple blood test
8. Scorecard to help in diabetic risk assessment of the Indian Population
9. Scorecard to help in diabetic risk assessment of the Indian Population
10. New technique to assess risk of fracture
11. Ofcom To Assess The Bedside Call Charges
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: